During our October federal advocacy drop-in session, we learned about several pieces of legislation that had a good chance to pass before the end of
Assorted News from the Last Week: CAC2 Individual Member Jennifer Flowers writes compellingly about “When the National Drug Shortage Becomes Personal” for her. Published in
By CAC2 Individual Member Jennifer Flowers Rhabdomyosarcoma became a common word in my family when I was three years old. By the time of diagnosis,
Assorted News from the Last Week: Last week the FDA reported that it is investigating reports of blood cancers — including life-threatening cases of myelodysplastic
Assorted News from the Last Week: In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations
In conjunction with the European Medicines Agency (EMA), the FDA Oncology Center of Excellence (OCE) held a one-hour Conversations on Cancer public panel discussion on
Assorted News from the Last Week: Electronic symptom screening in kids with cancer boosts quality of care. DIPG Research in Nature: brain tumor yields, in
By CAC2 Student Member Joshua Omale Attending the 2024 International Cancer Week, organized by Nigeria’s National Institute for Cancer Research and Treatment (NICRAT), was indeed
Assorted News from the Last Week: Navigating gatekeeping challenges in pediatric and young adult palliative oncology and end-of-life research. Active participation by patients and families
Assorted News from the Last Week: The NCI Fiscal Year 2026 Professional Judgment Budget Proposal highlights promising research areas and the optimal funding needed to
